FDA's Proposed Rule on LDT Regulation and the Debate over Agency Deference | Sheppard Mullin Richter & Hampton LLP
Earlier this month, the Food and Drug Administration (“FDA” or “the Agency”) issued a highly anticipated proposed rule outlining the regulatory framework and implementation plan for...